Tilray Brands (TLRY) Convertible Debt (2018 - 2026)
Tilray Brands (TLRY) reported Convertible Debt of $88.3 million for Q1 2026, down 15.18% on a YoY basis from $104.1 million in Q1 2025, and up 2.33% quarter-over-quarter from $86.3 million in Q4 2025.
Tilray Brands (TLRY) Convertible Debt (2018 - 2026) Analysis & Trends
Tilray Brands has reported Convertible Debt for 8 years, with the latest figure at $88.3 million in Q1 2026.
- For the quarter ending Q1 2026, Convertible Debt fell 15.18% year-over-year to $88.3 million; the trailing twelve-month figure through Feb 2026 stood at $88.3 million (down 15.18% YoY), and the FY2025 full-year result was $86.4 million, down 17.69% from the prior year.
- Convertible Debt for Q1 2026 stood at $88.3 million, up from $86.3 million in the prior quarter.
- The five-year high for Convertible Debt was $444.3 million in Q3 2022, with the low at $86.3 million in Q4 2025.
- Historically, Convertible Debt has averaged $169.4 million across 5 years, with a median of $123.2 million in 2023.
- Annual changes were most pronounced in 2023 — Convertible Debt sank 72.8% — and 2024, when it increased 9.75%.
- Tilray Brands' Convertible Debt stood at $223.3 million in 2022, then tumbled by 44.61% to $123.7 million in 2023, then retreated by 0.77% to $122.7 million in 2024, then fell by 29.72% to $86.3 million in 2025, then rose by 2.33% to $88.3 million in 2026.
- The last three Convertible Debt figures came in at $88.3 million (Q1 2026), $86.3 million (Q4 2025), and $100.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 88.27 Mn |
| Nov 30, 2025 | 86.26 Mn |
| Aug 31, 2025 | 100.00 Mn |
| May 31, 2025 | 86.43 Mn |
| Feb 28, 2025 | 104.07 Mn |
| Nov 30, 2024 | 122.74 Mn |
| Aug 31, 2024 | 132.65 Mn |
| May 31, 2024 | 105.00 Mn |
| Feb 29, 2024 | 126.59 Mn |
| Nov 30, 2023 | 123.69 Mn |
| Aug 31, 2023 | 120.86 Mn |
| May 31, 2023 | 221.04 Mn |
| Feb 28, 2023 | 223.09 Mn |
| Nov 30, 2022 | 223.30 Mn |
| Aug 31, 2022 | 444.28 Mn |
| May 31, 2022 | 401.95 Mn |
| May 31, 2020 | 350.00 Mn |
| Mar 31, 2020 | 432.81 Mn |
| Dec 31, 2019 | 430.21 Mn |
| Sep 30, 2019 | 427.98 Mn |